ArticleCurrent medicinal chemistry2025

FHL1 Inhibition by miR-1301-3p Promotes Uterine Corpus Endometrial Carcinoma Cell Proliferation and Migration: A Prognostic Insight.

Mengna Zhu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.